Bill

Bill > S4141


NJ S4141

Requires health insurance coverage of scalp cooling systems in connection with cancer chemotherapy treatment; requires physicians to inform patients of scalp cooling therapy.


summary

Introduced
02/20/2025
In Committee
02/20/2025
Crossed Over
Passed
Dead

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill requires health insurance carriers (insurance companies, health, hospital, and medical service corporations, health maintenance organizations, and State and School Employees' Health Benefits Program contracts) to provide coverage for scalp cooling systems used in connection with cancer chemotherapy treatment. Pursuant to the bill, "scalp cooling system" means any device used to cool the human scalp to prevent or reduce hair loss during cancer chemotherapy treatment, so long as the device is designed and intended for repeated use and is primarily and customarily used to serve a medical purpose. In addition, the bill requires physicians administering cancer chemotherapy to a patient to inform the patient, prior to the initiation of treatment, of the availability of scalp cooling therapy as an option to help prevent or reduce hair loss and to maintain a record of the discussion in the patient's medical records.

AI Summary

This bill requires various types of health insurance providers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, health benefits plans, health maintenance organizations, and state employee health plans, to provide coverage for scalp cooling systems used during cancer chemotherapy treatment. A scalp cooling system is defined as a device designed to cool the human scalp to prevent or reduce hair loss during chemotherapy, intended for repeated medical use. The bill mandates that these insurance coverage requirements apply to new and renewed contracts where the insurer has reserved the right to change premiums. Additionally, the bill requires physicians administering chemotherapy to inform patients about scalp cooling therapy as an option for preventing or reducing hair loss before treatment begins and to document this discussion in the patient's medical records. The provisions of the bill will take effect 180 days after enactment, applying to insurance contracts delivered, issued, executed, or renewed on or after that date.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 02/20/2025)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...